Pulmonary manifestations of cystic fibrosis (CF) are responsible for almost
90% of the disease-related mortality. The relationship between CFTR dysfun
ction and pathophysiology of lung disease is still unclear. The abnormally
high absorption of airway liquid depletes the periciliar liquid layer and i
mpairs mucociliary clearance as part of the local immune defense. Besides a
irway colonisation with pathogens like Staphylococcus aureus, Haemophilus i
nfluenzae, Pseudomonas aeruginosa and Burkholderia cepacia peripheral bronc
hioles are obstructed by mucous plugs. The course of lung disease is determ
ined by marked neutrophilic bronchial inflammation which may be causally re
lated to the CFTR defect itself. This leads to bronchiectases, destruction
of the lung and finally respiratory insufficiency. Different approaches to
symptomatic therapy have been developed which resulted in a dramatic improv
ement of life expectancy within the last decades.